Palbociclib in Combination With Bicalutamide for the Treatment of AR(+) Metastatic Breast Cancer (MBC)
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer (MBC)
Interventions: DRUG: Palbociclib|DRUG: Bicalutamide
Sponsor: Memorial Sloan Kettering Cancer Center
Collaborators: Pfizer